These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 331821)

  • 21. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of tardokrein in vascular diseases of the nervous system].
    Wasilewski R; Rubach K; Bortnowska M
    Neurol Neurochir Pol; 1972; 6(5):855-60. PubMed ID: 4655989
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of the action of Trivastal in neurosurgery].
    Vigouroux RP
    Mars Med; 1972; 109(3):251-2. PubMed ID: 5057267
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term medical treatment of acute cerebrovascular disease sequelae (comparison papaverine-piribedil].
    Piccinelli A; Neri G; Agnoli A
    Minerva Med; 1974 Nov; 65(80):4199-213. PubMed ID: 4610451
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the cerebral effectiveness of oral Tropodil therapy].
    Steinbach M
    Med Klin; 1968 Feb; 63(6):222-3. PubMed ID: 5662364
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cyclandelate on cerebral cortex perfusion-rates in cerebrovascular disease.
    O'Brien MD; Veall N
    Lancet; 1966 Oct; 2(7466):729-30. PubMed ID: 4162060
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclandelate and mental functions: a double-blind cross-over trial in normal elderly subjects.
    Judge TG; Urquhart A; Blakemore CB
    Age Ageing; 1973 May; 2(2):121-4. PubMed ID: 4591604
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P; Tschabitscher H
    Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the effect of a new coronary vessel dilating substance, carbochromen, on the blood circulation and metabolism of the brain].
    Yamaoka S; Okada T; Kawamura M; Saito Y
    Med Welt; 1968 Mar; 12():764-70. PubMed ID: 5728935
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 31. [The evaluation of the vasomotor cerebrovascular action of vasoactive substances by using gamma scintigraphy].
    Shtok VN; Kasatkin IuN; Eremeeva SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):46-9. PubMed ID: 1332330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proxazole in cerebrovascular insufficiency. A controlled clinical trial.
    Esposito G; De Gregorio M
    Arzneimittelforschung; 1974 Oct; 24(10):1692-6. PubMed ID: 4611436
    [No Abstract]   [Full Text] [Related]  

  • 33. [Benfurodil hemisuccinate in cerebrovascular pathology].
    Lehembre P; Warot P
    Lille Med; 1974 Apr; 19(4 Suppl 11):525-7. PubMed ID: 4612281
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of vasodilators on the cerebral circulation].
    Miyazaki M
    Naika; 1967 Jan; 19(1):141-5. PubMed ID: 6060632
    [No Abstract]   [Full Text] [Related]  

  • 35. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
    Merchan R; Zurita IE; Martinez JF
    Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind trial of suloctidil v. placebo in intermittent claudication.
    Jones NA; De Haas H; Zahavi J; Kakkar VV
    Br J Surg; 1982 Jan; 69(1):38-40. PubMed ID: 6274471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug therapy: cerebral vasodilators (first of two parts).
    Cook P; James I
    N Engl J Med; 1981 Dec; 305(25):1508-13. PubMed ID: 7029283
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N; Kusunoki T; Matsumoto S
    Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial.
    Chieffo C; Postiglione A; Tritto C; Mancini M
    Curr Med Res Opin; 1984; 9(3):147-52. PubMed ID: 6094103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent claudication: Suloctidil v.s. placebo treatment.
    Holm J; Lindblad L; Scherstén T; Suurkula M
    Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.